NASDAQ:DBVT - DBV Technologies S.A.
$7.71
 $-0.15
-1.91%
1:55PM EDT
2019-02-15
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  DBVT     avg for
industry  
  avg for
sector  
42 stocks weight:  27. 94   0. 00   0. 00  
42 stocks rank:  3. 39 K 1. 86 K 1. 09 K
# analyst opinions:  9. 00   14. 92   14. 43  
mean recommendation:  2. 40   1. 91   1. 93  

quick ratio:  6. 51   5. 37   1. 81  
current ratio:  6. 59   5. 69   2. 19  

target price low:  5. 63   88. 97   117. 82  
target price avg:  7. 90   115. 19   141. 96  
target price high:  20. 51   143. 40   163. 16  
1-yr high:  25. 86   124. 30   142. 77  
last close:  7. 86   101. 85   127. 84  
50-day avg:  8. 78   98. 27   122. 46  
200-day avg:  17. 32   99. 72   122. 70  
1-yr low:  5. 75   78. 19   100. 16  
volume:  256. 14 K 2. 38 M 4. 64 M
50-day avg volume:  890. 86 K 3. 31 M 4. 94 M
200-day avg volume:  322. 65 K 3. 23 M 4. 28 M

1-day return:  11. 49 % 0. 22 % 0. 48 %
this week return:  13. 75 % 1. 77 % 2. 01 %
12-wk return:  -47. 35 % 6. 56 % 3. 33 %
52-wk return:  -72. 89 % -2. 23 % 14. 35 %

enterprise value (EV):  327. 06 M 55. 17 B 104. 51 B
market cap:  467. 49 M 49. 01 B 96. 46 B
debt/equity:  1. 76   258. 01   110. 73  

shares outstanding:  29. 98 M 607. 99 M 1. 22 B
shares:  25. 73 M 605. 53 M 1. 15 B
shares short:  1. 60 M 11. 62 M 12. 55 M
shares short prior month:  1. 99 M 11. 95 M 13. 44 M
short ratio:  1. 37   4. 82   3. 10  

book value:  3. 98   14. 43   28. 26  
price/book:  1. 97   -1. 57   -2. 97  
gross profits:  9. 60 M 8. 28 B 18. 09 B
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  100. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  -59. 29 % --- ---
1-yr mean volatility:  -0. 31 % 0. 01 % 0. 06 %

1-yr EPS:  -3. 27   3. 03   4. 09  
forward EPS:  -4. 41   4. 33   6. 99  
P/E:  -2. 41   6. 11   26. 91  
forward P/E:  -1. 60   8. 38   10. 48  
PE/G:  0. 28   0. 37   5. 61  
growth:  -8. 70 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -37. 74 % -3. 27 % 3. 81 %
return on equity:  -74. 24 % 107. 48 % 27. 82 %
revenue growth:  -8. 70 % 648. 36 % 97. 70 %

beta (1yr vs S&P500):  1. 12   1. 21   0. 93  
sharpe (1yr):  -1. 00   0. 06   0. 98  

held % insiders:  0. 00 % 6. 46 % 3. 21 %
held % institutions:  48. 31 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : DBVT
.        + 0 =             0 :: INITIAL WEIGHT
.  + 534.518 =       534.518 :: inverse volume-to-price addition
.  + 117.235 =       651.753 :: spline projection addition
.   - 160.37 =       491.383 :: poor performance penalty
.    x 0.615 =       302.122 :: one-year gains+dividend factor
.    x 8.019 =      2422.752 :: 13 weeks' performance factor
.    x 1.492 =       3615.93 :: industry recommendation factor
.    x 1.408 =      5090.673 :: symbol recommendation factor
.    x 0.996 =       5071.46 :: return on assets factor
.    x 0.993 =      5033.808 :: return on equity factor
.    x 0.999 =      5029.429 :: revenue growth factor
.    x 2.842 =     14292.884 :: current ratio factor
.    x 1.087 =     15535.184 :: quick ratio factor
.    x 1.315 =     20432.914 :: short ratio factor
.     x 2.02 =      41269.25 :: price-to-book factor
.    x 1.003 =     41409.449 :: debt-to-equity factor
.    x 2.162 =     89519.436 :: P/E weight
.    x 1.379 =    123432.333 :: PE/G factor
.    x 1.547 =    190938.544 :: beta factor
.    x 0.999 =    190806.956 :: sharpe factor
.    x 0.947 =    180634.531 :: target low factor
.    x 1.024 =    184929.878 :: target mean factor
.    x 1.127 =    208390.583 :: target high factor
.    x 1.066 =    222063.674 :: industry 12-weeks return
.    x 0.918 =    203962.728 :: "drift" penalty 5 days ago
.    x 0.999 =    203684.776 :: overall "drift" factor
.    x 0.998 =    203179.457 :: largest single-day jump factor
.    x 0.107 =     21800.371 :: low price factor
.      x 1.0 =     21801.834 :: factor hist industry gain for week 06
.   cubeRoot =        27.936 :: reduced for readability
.                     27.936 :: FINAL WEIGHT for NASDAQ:DBVT


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org